Welcome to kongre.net
Speaker
Senior Principal Scientist, Bristol Myers Squibb
Jack Sloane, Senior Principal Scientist at Bristol Myers Squibb, spoke at 4th Covalent Drug Discovery & Development Summit (Boston, United States of America, 20–22 Oct 2026) in the session “Unlocking Novel Covalent Reactivity in KRAS G12C Through Innovative Warhead Design”.
20–22 Oct 2026Boston, United States of America
Executive Director, Aclaris Therapeutics
Associate Professor, Biological Chemistry & Molecular Pharmacology, Dana-Farber Cancer Institute
Associate Director, Chemical Biology & Proteomics, Dunad Therapeutics
Core Director, Dana-Farber Cancer Institute
Director, Eli Lilly
Director & Head of Discovery Biology, Frontier Medicines
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Jack Sloane, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].